LOS ANGELES, Dec. 20, 2010 /PRNewswire/ -- Neutrogena, the #1 dermatologist-recommended suncare brand, recently called upon The Creative Coalition, to help educate the Hollywood creative community to change the way sun habits are portrayed in film and TV.
In early 2010 skin cancer was officially acknowledged as an epidemic in the U.S. and more than 1 million cases of skin cancer will be diagnosed by the end of the year. Additionally, given this year's alarming statistic and heightened awareness, skin cancer and sun protection have been more prevalent in the media. However, prior to these announcements, and through an ongoing effort to educate Americans on the dangers of tanning and the importance of year-round sun protection, Neutrogena developed a multi-pronged skin health initiative, Choose Skin Health, in 2008. This year, as part of this larger campaign, Neutrogena, in partnership with the Creative Coalition, will combine sun care thought leadership with entertainment industry influence to communicate facts about skin cancer and convey the urgency of sending positive messages to the American public about sun protection.
"As the suncare leader, Neutrogena has a responsibility to educate on the importance of sun safety," said Jim Colleran, President of Neutrogena Corporation. "We know films and television greatly influence consumer behavior, especially that of young adults, and we designed this initiative to start a dialogue to reinforce the importance of sun protection and de-glamorize tanning within pop culture. Neutrogena is hopeful that this campaign will gain the same momentum as the campaign to end onscreen tobacco use."
Understanding that melanoma is 99% preventable, affects people of all ages and is the #1 cancer for women in their 20's, earlier this year, Neutrogena conducted a nationwide study to further understand America's sun protection habits. The study confirmed most (94%) Americans know prolonged sun exposure can cause skin damage and skin cancer- yet only 20% of people wear sunscreen daily. With the insight that film and television transmit and influence ideals of beauty, Neutrogena seeks to empower the arts and entertainment industry leaders to be at the forefront of the movement to change sun practices of Americans.
As part of Neutrogena's Choose Skin Health campaign, and long-standing commitment to education around safe sun behavior and practices, Neutrogena will work with The Creative Coalition to provide educational resources on safe sun practices to actors, writers, producers and directors. Neutrogena also announced their commitment to supply movie and television sets with sun protection products and cosmetics with SPF.
"The Creative Coalition is proud to be working with Neutrogena in this innovative alliance that leverages the arts and entertainment industry to positively impact a public health crisis," said Robin Bronk, Chief Executive Officer.
To learn more about the broader Neutrogena sun education campaign, Choose Skin Health, please visit csh.neutrogena.com.
A worldwide leader in premium, dermatologist-recommended skin, hair and cosmetics products, Neutrogena® Corporation has been providing consumers with health and beauty improvements for over 40 years. The Company manufactures and markets a line of premium-priced skin and hair care products that are distributed in more than 70 countries. Headquartered in Los Angeles, Neutrogena® is a subsidiary of Johnson & Johnson, the world's most comprehensive and broadly based health care products company.
About The Creative Coalition (www.thecreativecoalition.org)
The Creative Coalition is a premiere 501(c)(3) nonprofit, nonpartisan social and public advocacy organization of the arts and entertainment community. Founded in 1989 by prominent members of the creative community, The Creative Coalition is dedicated to educating and mobilizing its members on issues of public importance, primarily public education, the First Amendment, and arts advocacy, and is headquartered in New York City.
(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Neutrogena® and/or Johnson & Johnson's expectations and projections. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended January 3, 2010. Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Neither Neutrogena® nor Johnson & Johnson undertake to update any forward-looking statements as a result of new information or future events or developments.)